NCT01813760CompletedNot Applicable
Treatment of Periorbital and Perioral Wrinkles With the Applications of the Iluminage Diode Laser
Conditions
Interventions
Trial Snapshot
- Phase
- Not Applicable
- Status
- Completed
- Sponsor
- Cynosure, Inc.
- Enrollment
- 60
- Locations
- 1
- Primary Endpoint
- Photographic Evaluation
Study Overview
Brief Summary
The Diode laser system is being used in this marketing study for the treatment of wrinkles around the eyes and mouth.
Study Design
- Study Type
- Interventional
- Allocation
- Na
- Intervention Model
- Single Group
- Primary Purpose
- Treatment
- Masking
- None
Eligibility Criteria
- Ages
- 35 Years to 60 Years (Adult)
- Sex
- Female
- Accepts Healthy Volunteers
- No
Inclusion Criteria
- •Subjects who are healthy females between 35 and 60 years of age.
- •Subjects who have Fitzpatrick skin type I-VI
- •Subjects who have provided written and verbal informed consent
- •Subjects who are willing and able to comply with study instructions and to return to the clinic for required visits and have photographs of their face taken
- •Subjects who have perioral and periorbital wrinkles, as deemed appropriate by the Investigator or his designees
Exclusion Criteria
- •Subjects who currently use or have used in the prior 30 days any skin products that contain alpha hydroxy acids (AHA) e.g. glycolic, lactic, citric, or mendelic acid containing products or retinol/tretinoin containing products or exfoliating washes, masks or scrubs or other micro-dermabrasion skin care products. on the laser application areas
- •Subjects who are unwilling to maintain their daily skin care regimen for the duration of the study,
- •Subjects who have any skin pathology or condition that could interfere with the evaluation i.e. personal or family history of skin cancer, rosacea and/or requires the use of interfering topical or systemic therapies.
- •Subjects with synthetic or metal implants or permanent cosmetic tattoos in the test areas
- •Subjects who have a history of abnormal scarring, e.g. keloids or have significant scarring in the areas to be treated
- •Subjects with bleeding disorders or taking anticoagulation medications, including heavy use of aspirin
- •Subjects who have participated in any clinical investigation involving the face within the 30 days prior to the first planned laser application or subjects who plan to participate in concomitant facial studies during this trial
- •Subjects, who are pregnant, were pregnant or gave birth in the last 3 months, are currently breast feeding, or might become pregnant during the course of the study
- •Subjects who have a history of light triggered seizures
- •Subjects with prior use of neurotoxins e.g. Botox®, collagen, fat injections and/or other methods of skin augmentation (enhancement with injected or implanted material) of the face or having had chemical peels within 6 months of initial laser application or planning to so during the course of the study
- •Subject's use of oral isotretinoin (Accutane®) within 12 months of initial laser application or during the course of the study
- •Subjects having had facial skin treatments with any professional laser, light based, radiofrequency or other devices within the last year
- •Subjects ever having facial skin treatments with home use laser, light based or radiofrequency or other devices, i.e. PaloVia® or Tria®
Arms & Interventions
Diode laser
Experimental
Diode laser to treat peri-orbital and peri-oral wrinkles
Intervention: Illuiminage ® Diode Laser (Device)
Outcomes
Primary Outcomes
Photographic Evaluation
Time Frame: 60 days post first treatment
Compare severity of wrinkles from baseline to 60 days post treatment based on Fitpatrick Scale.
Secondary Outcomes
- Number of Participants with Adverse Events(up to 4 months post 1st treatment)
- Photographic Evaluation(Up to 40 days)
Investigators
Study Sites (1)
Loading locations...
Similar Trials
Completed
Phase 3
S-Caine™ Peel (Skin Numbing Cream) to Treat Pain During Non-Ablative Facial Laser Resurfacing in AdultsPainNCT00110747ZARS Pharma Inc.54
Completed
Not Applicable
Treatment of Keratosis Pilaris With 810 nm Diode LaserKeratosis Pilaris (KP)NCT01281644Northwestern University23
Completed
Not Applicable
Evaluation of Diode Laser and Topical Steroid Therapy in the Treatment of Erosive Oral Lichen PlanusErosive Oral Lichen PlanusNCT05951361Alexandria University44
Unknown
Not Applicable
Laser Peripheral Iridotomy Plus Laser Peripheral Iridoplasty for Primary Angle ClosureGlaucoma, Angle-ClosureNCT02613013Sun Yat-sen University240
Completed
Not Applicable
Treatment of Dilated Blood Vessels on the Cheeks With a New Yellow Laser and a Traditional Green LaserTelangiectasiaRosaceaNCT03472859Tampere University Hospital24